Mercado de biopsia con aguja en Oriente Medio y África: tendencias de la industria y pronóstico hasta 2028

Análisis y perspectivas del mercado: mercado de biopsia con aguja en Oriente Medio y África

Se espera que el mercado de biopsia con aguja de Oriente Medio y África gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 3,7% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 32,53 millones para 2028 desde USD 24,46 millones en 2020.

Una biopsia con aguja es un procedimiento manual, guiado por imágenes o por ultrasonido, que se utiliza para obtener una muestra de células del cuerpo humano para realizar pruebas de laboratorio o de diagnóstico, especialmente del tumor. Los procedimientos comunes de biopsia con aguja incluyen la biopsia por aspiración con aguja fina y la biopsia con aguja gruesa. Cuando un médico identifica un bulto anormal, o cuando las exploraciones por imágenes muestran la presencia de anomalías en el cuerpo, entonces el uso de biopsias con aguja entra en su lugar. Las biopsias con aguja se utilizan regularmente para detectar y diagnosticar el cáncer de mama , el cáncer de pulmón y otros tipos de cáncer, pero también se utilizan para encontrar una infección, hacer coincidir los tejidos de los órganos, hacer coincidir los tejidos de los órganos antes de un trasplante y encontrar el daño a los nervios en el cuerpo humano.

Existen cuatro tipos diferentes de biopsias con aguja. La biopsia por aspiración con aguja fina utiliza una aguja fina de varios centímetros de largo. Se utiliza una jeringa para extraer las células, los tejidos y los líquidos. La biopsia con aguja gruesa utiliza una aguja hueca ancha que extrae los trozos de tejido del área de examen. Mediante el uso de una imagen en tiempo real, la biopsia guiada por imágenes permite al médico guiar la aguja hacia la mejor posición para obtener una muestra de células sospechosas. Permite al médico detectar áreas sospechosas que no se ven o se sienten fácilmente a través de la piel del individuo, como la glándula prostática, la glándula tiroides y la glándula gastrointestinal. La biopsia con aguja asistida por vacío utiliza un introductor hueco, que se coloca en su lugar con la guía de imágenes.

The increase in prevalence of lung, prostate and breast cancer, rise in government initiatives for awareness about treatment of lung, prostate and breast cancer and increased demand for minimally invasive surgeries pave the way for the growth of needle biopsies market. Moreover, the strategic initiatives by market players and growth potential in emerging economies for needle biopsy and rise in product approvals bolsters the needle biopsy market growth. However the rise in cost of needle biopsies the stringent regulations imposed and the needle biopsy being inaccessible to developing countries are the restraints which can hinder the market growth. The side effects incurred while using needle biopsies in the material used are the restraints which can hinder the market growth.

The needle biopsy market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Needle Biopsy Market Scope and Market Size

Needle biopsy market is segmented on the basis of needle type, ergonomics procedure, sample site, utility, application, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of needle type, the needle biopsy market is segmented into trephine biopsy needles, klima sternal needle, salah needle aspiration needle, jamshidi needle and others. In 2021, the trephine biopsy needles segment is expected to dominate dominating the needle biopsies needle biopsy market due to its overall assessment of morphology and being used as an alternative to fine needle biopsy are predicted to dominate the market.
• On the basis of ergonomics, the needle biopsy market is segmented into sharp, blunt, quincke, chiba, franseen and others. In 2021 the sharp segment is expected to dominate the needle biopsies needle biopsy market due owing to its accurate precision of detection and diagnosis of the cancer tumor.
• On the basis of procedure, the needle biopsy market is segmented into fine- needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy. In 2021, the fine- needle aspiration biopsy segment is expected to dominate the needle biopsy market since it’s minimally invasive, provides rapid and effective diagnostic result. It provides rapid and effective diagnostic results to determine the status of the suspected tissue and timely diagnosis and treatment are predicted to dominate the market.
• On the basis of sample site, the needle biopsy market is segmented into muscles, bones and other organs. In 2021, the muscle segment is expected to dominate the needle biopsies needle biopsy market, since it provides the source of the disease process and a better diagnostic approaches are predicted to dominate the market.
• On the basis of utility, the needle biopsy market is segmented into disposable and reusable. In 2021, the disposable segment is expected to dominate is dominating the needle biopsy market, since the needle biopsy can be used once and disposed of carefully and the chances of infection are less are predicted to dominate the market.
• On the basis of application, the needle biopsy market is segmented into tumor, infection, inflammation and others. In 2021, the tumor segment is expected to dominate the needle biopsy market due to increased cases of malignant tumor the needle biopsy market due to increased malignant tumor cases in breast cancer and lung cancer and ease of localization and detection.
• On the basis of end user, the needle biopsies needle biopsy market is segmented into hospitals, diagnostic centers, biopsy labs, ambulatory surgical centers, academic and research organizations and others. In 2021, the hospitals segment is expected to dominate the needle biopsy market due to the increased need for treatment of cancer and the availability of needle biopsies needle biopsyare predicted to dominate the market.
• On the basis of distribution channel, the needle biopsies needle biopsy market is segmented into direct tender, retail sales. In 2021, direct tender segment is expected to dominate the needle biopsy market due to the rise in access to fine fine-needle aspiration biopsies, surge in a number of biopsies on a daily basis and rise in a number of contacts for the supply of diagnostic medications and needle biopsies needle biopsy are predicted to dominate the market.

Middle East and Africa Needle Biopsy Market Country Level Analysis

The needle biopsy market is analysed and market size information is provided by needle type, ergonomics procedure, sample site, utility, application, end user and distribution channel as referenced above.

The countries covered in the Middle-East and Africa needle biopsy market report are the South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.

Middle East and Africa is expected to grow with the substantial growth rate in the forecast period of 2021 to 2028 as Middle East and Africa counties are major developing countries and focus on increasing R&D activities in pharma and biotech sector and increase outsourcing services. South Africa is expected to dominate in the market in the Middle East and Africa market.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

The Growth Potential for the Needle Biopsy in Emerging Economies and the Strategic Initiatives by Market Players are creating new Opportunities in the Middle East and Africa Needle Biopsy Market.

Needle biopsy market also provides you with detailed market analysis for every country growth in particular industry with needle biopsy sales, impact of advancement in the needle biopsy and changes in regulatory scenarios with their support for the needle biopsy market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Middle East and Africa Needle Biopsy Market Share Analysis

Middle East and Africa needle biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to needle biopsy market.

The major companies providing the Middle East and Africa needle biopsy market are Boston Scientific Corporation, Hologic, Inc. AprioMed AB, Cardinal Health, BD, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players along with new technological advancements for needle biopsy is bridging the gap for needle biopsy market. 

For instance,

• En abril de 2014, AprioMed AB había colaborado con Cenova. Apriomed, Inc. había lanzado un producto, AprioCore plus, en los Estados Unidos. La colaboración significaba que Cenova, el actor del mercado, sería responsable del embalaje y la logística de los productos fabricados en Apriomed Inc. La incorporación de un nuevo producto mejoraría la colaboración.

La colaboración, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de biopsia con aguja en Oriente Medio y África, lo que también proporciona el beneficio para que la organización mejore su oferta de productos de tratamiento.

SKU-64210